Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab170705 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Patritumab (anti-ERBB3)
- Antibody type
- Recombinant
- Description
- Patritumab (anti-ERBB3) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (C411992), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human, Rat
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Patritumab (anti-ERBB3) (Ab170705) - ELISA Immobilized Recombinant Human ErbB3 / HER3 protein (rp170123) at 1.0 μg/mL can bind Patritumab (anti-ERBB3) (Ab170705) with the EC₅₀ of 27.08 ng/mL.
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Patritumab (anti-ERBB3) (Ab170705) - Flow Cytometry Flow Cytometry analysis of MCF-7 cells labelling ERBB3 (red) with Patritumab (anti-ERBB3) (Ab170705). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
